Antioxidant effects of statins by modulating Nrf2 and Nrf2/HO-1 signaling in different diseases

A Mansouri, Ž Reiner, M Ruscica… - Journal of Clinical …, 2022 - mdpi.com
Statins are competitive inhibitors of hydroxymethylglutaryl-CoA (HMG-CoA) reductase and
have been used to treat elevated low-density lipoprotein cholesterol (LDL-C) for almost four …

[HTML][HTML] Dyslipidemia and diabetes mellitus: Role of lipoprotein species and interrelated pathways of lipid metabolism in diabetes mellitus

JP Kane, CR Pullinger, ID Goldfine… - Current opinion in …, 2021 - Elsevier
Diabetes mellitus is a complex disease. We are increasingly gaining a better understanding
of its mechanisms at the molecular level. From these new insights, better therapeutic …

[HTML][HTML] Coenzyme Q10 supplementation–In ageing and disease

J Aaseth, J Alexander, U Alehagen - Mechanisms of ageing and …, 2021 - Elsevier
Abstract Coenzyme Q 10 (CoQ 10) is an essential component of the mitochondrial electron
transport chain. It is also an antioxidant in cellular membranes and lipoproteins. All cells …

Improved COVID‐19 outcomes following statin therapy: an updated systematic review and meta‐analysis

A Vahedian-Azimi, SM Mohammadi… - BioMed research …, 2021 - Wiley Online Library
Background. Although vaccine rollout for COVID‐19 has been effective in some countries,
there is still an urgent need to reduce disease transmission and severity. We recently carried …

A comprehensive review on the lipid and pleiotropic effects of pitavastatin

A Sahebkar, N Kiaie, AM Gorabi, MR Mannarino… - Progress in Lipid …, 2021 - Elsevier
Abstract The 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, or
statins, are administered as first line therapy for hypercholesterolemia, both in primary and …

Emerging antioxidant paradigm of mesenchymal stem cell-derived exosome therapy

C Xia, Z Dai, Y Jin, P Chen - Frontiers in Endocrinology, 2021 - frontiersin.org
Mesenchymal stem cell-derived exosomes have been under investigation as potential
treatments for a diverse range of diseases, and many animal and clinical trials have …

Foam cells as therapeutic targets in atherosclerosis with a focus on the regulatory roles of non-coding RNAs

A Javadifar, S Rastgoo, M Banach… - International journal of …, 2021 - mdpi.com
Atherosclerosis is a major cause of human cardiovascular disease, which is the leading
cause of mortality around the world. Various physiological and pathological processes are …

Vulnerable atherosclerotic plaque: is there a molecular signature?

RM Chiorescu, M Mocan, AI Inceu, AP Buda… - International Journal of …, 2022 - mdpi.com
Atherosclerosis and its clinical manifestations, coronary and cerebral artery diseases, are
the most common cause of death worldwide. The main pathophysiological mechanism for …

Polypharmacy and malnutrition management of elderly perioperative patients with cancer: a systematic review

E Kose, H Wakabayashi, N Yasuno - Nutrients, 2021 - mdpi.com
Malnutrition, which commonly occurs in perioperative patients with cancer, leads to
decreased muscle mass, hypoalbuminemia, and edema, thereby increasing the patient's …

Mitochondrial fission as a therapeutic target for metabolic diseases: insights into antioxidant strategies

T Yu, L Wang, L Zhang, PA Deuster - Antioxidants, 2023 - mdpi.com
Mitochondrial fission is a crucial process in maintaining metabolic homeostasis in normal
physiology and under conditions of stress. Its dysregulation has been associated with …